HNB
MRSN

Huntington National Bank’s Mersana Therapeutics MRSN Stock Holding History

Huntington National Bank’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32
Closed -$926 – 4253
2025
Q4 		$926 Hold
32
– – ﹤0.01% 2286
2025
Q3 		$248 Hold
32
– – ﹤0.01% 2512
2025
Q2 		$237 Hold
32
– – ﹤0.01% 2571
2025
Q1 		$275 Buy
+32
New +$494 ﹤0.01% 2570

Other funds holding MRSN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank's MRSN Position: Q1 2026 in Review

Huntington National Bank sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 32 shares — an estimated $926 sold.

Huntington National Bank first reported a position in MRSN in Q1 2025 and held it in 4 quarters. The position peaked at $926 in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

  • Huntington National Bank reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Huntington National Bank sold 32 Mersana Therapeutics shares in Q1 2026, an estimated $926.
  • Huntington National Bank first reported a position in Mersana Therapeutics in Q1 2025 and held it in 4 quarters.
  • Huntington National Bank's Mersana Therapeutics position peaked at $926 in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.